Ribrag V - Search Results

1

High level of glutathione-S-transferase pi expression in mantle cell lymphomas.

Bennaceur-Griscelli A, Bosq J, Koscielny S, Lefrère F, Turhan A, Brousse N, Hermine O, Ribrag V. Bennaceur-Griscelli A, et al. Among authors: ribrag v. Clin Cancer Res. 2004 May 1;10(9):3029-34. doi: 10.1158/1078-0432.ccr-03-0554. Clin Cancer Res. 2004. PMID: 15131039

2

Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems.

Massaad L, de Waziers I, Ribrag V, Janot F, Beaune PH, Morizet J, Gouyette A, Chabot GG. Massaad L, et al. Among authors: ribrag v. Cancer Res. 1992 Dec 1;52(23):6567-75. Cancer Res. 1992. PMID: 1423302

3

Aggressive acute CD3+, CD56- T cell large granular lymphocyte leukemia with two stages of maturation arrest.

Tordjman R, Macintyre E, Emile JF, Valensi F, Ribrag V, Burtin ML, Varet B, Brousse N, Hermine O. Tordjman R, et al. Among authors: ribrag v. Leukemia. 1996 Sep;10(9):1514-9. Leukemia. 1996. PMID: 8751472

4

Carcinoma cell leukemia.

Nasr F, Corti C, Carde P, Ribrag V, Valensi F, Bayle C, Turhan AG, Bosq J. Nasr F, et al. Among authors: ribrag v. Blood. 1996 Sep 15;88(6):2355-7. Blood. 1996. PMID: 8822959 Free article. No abstract available.

5

Mantle cell lymphomas: characteristics, natural history and prognostic factors of 45 cases.

Decaudin D, Bosq J, Munck JN, Bayle C, Koscielny S, Boudjemaa S, Bennaceur A, Venuat AM, Naccache P, Bendahmane B, Ribrag V, Carde P, Pico JL, Hayat M. Decaudin D, et al. Among authors: ribrag v. Leuk Lymphoma. 1997 Aug;26(5-6):539-50. doi: 10.3109/10428199709050890. Leuk Lymphoma. 1997. PMID: 9389361

6

Glutathione system, topoisomerase II level and multidrug resistance phenotype in acute myelogenous leukemia before treatment and at relapse.

Massaad-Massade L, Ribrag V, Marie JP, Faussat AM, Bayle C, Dreyfus F, Gouyette A. Massaad-Massade L, et al. Among authors: ribrag v. Anticancer Res. 1997 Nov-Dec;17(6D):4647-51. Anticancer Res. 1997. PMID: 9494583

7

VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin's disease.

Ribrag V, Nasr F, Bouhris JH, Bosq J, Brault P, Girinsky T, Cosset JM, Munck JN, Corti C, Decaudin D, Pico JL, Hayat M, Carde P. Ribrag V, et al. Bone Marrow Transplant. 1998 May;21(10):969-74. doi: 10.1038/sj.bmt.1701202. Bone Marrow Transplant. 1998. PMID: 9632268 Clinical Trial.

8

Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice.

Vantelon JM, Koscielny S, Brault P, Bourhis JH, Ribrag V, Pico J, Fenaux P, Munck JN. Vantelon JM, et al. Among authors: ribrag v. Bone Marrow Transplant. 2000 Mar;25(5):495-9. doi: 10.1038/sj.bmt.1702201. Bone Marrow Transplant. 2000. PMID: 10713625 Clinical Trial.

9

Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx.

Ribrag V, Ell Hajj M, Janot F, Girinsky T, Domenge C, Schwaab G, Fenaux P, Bosq J. Ribrag V, et al. Leukemia. 2001 Jul;15(7):1123-6. doi: 10.1038/sj.leu.2402148. Leukemia. 2001. PMID: 11455983

10

A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment.

Girinsky T, Guillot-Vals D, Koscielny S, Cosset JM, Ganem G, Carde P, Monhonval M, Pereira R, Bosq J, Ribrag V, Vantelon JM, Munck JN. Girinsky T, et al. Among authors: ribrag v. Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):148-55. doi: 10.1016/s0360-3016(01)01626-1. Int J Radiat Oncol Biol Phys. 2001. PMID: 11516864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters